Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023

SELL
$1.73 - $3.77 $26,110 - $56,900
-15,093 Reduced 7.34%
190,605 $470,000
Q3 2022

Nov 04, 2022

BUY
$3.53 - $6.9 $5,725 - $11,191
1,622 Added 0.79%
205,698 $743,000
Q2 2022

Aug 04, 2022

SELL
$4.5 - $8.96 $49,963 - $99,482
-11,103 Reduced 5.16%
204,076 $986,000
Q1 2022

Apr 25, 2022

BUY
$7.08 - $8.88 $15,760 - $19,766
2,226 Added 1.05%
215,179 $1.88 Million
Q4 2021

Jan 21, 2022

BUY
$7.09 - $8.7 $9,748 - $11,962
1,375 Added 0.65%
212,953 $1.64 Million
Q3 2021

Oct 27, 2021

BUY
$7.4 - $10.2 $40,559 - $55,906
5,481 Added 2.66%
211,578 $1.71 Million
Q2 2021

Jul 26, 2021

BUY
$8.25 - $11.62 $629,062 - $886,024
76,250 Added 58.72%
206,097 $2.1 Million
Q1 2021

Apr 23, 2021

BUY
$7.08 - $10.03 $919,316 - $1.3 Million
129,847 New
129,847 $1.17 Million

Others Institutions Holding BWAY

About Brainsway Ltd.


  • Ticker BWAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,519,200
  • Market Cap $153M
  • Description
  • Brainsway Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, Europe, Israel, and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addictio...
More about BWAY
Track This Portfolio

Track Taylor Frigon Capital Management LLC Portfolio

Follow Taylor Frigon Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Taylor Frigon Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Taylor Frigon Capital Management LLC with notifications on news.